Eloxx Pharmaceuticals Reports First Quarter 2018 Financial And Operating Results And Provides Business Update | Latest News RSS feed

Eloxx Pharmaceuticals Reports First Quarter 2018 Financial And Operating Results And Provides Business Update - Latest News


Eloxx Pharmaceuticals Reports Second Quarter 2018 Financial and Operating Results and Provides Business Update

Aug. 07, 2018 (GLOBE NEWSWIRE) -- Eloxx Pharmaceuticals ... today reported its financial results for the three and six months ended June 30, 2018 and provided a business update. “We are pleased to hav... read more

Eloxx Pharmaceuticals' (ELOX) CEO Robert Ward on Q2 2018 Results - Earnings Call Transcript

Thank you, Sara, and welcome and thank you to joining us – those of you joining us this afternoon for a review of Eloxx Pharmaceuticals’ Second Quarter 2018 Financial Results and Business Update ... t... read more

Dicerna Reports Second Quarter 2018 Financial and Operating Results and Provides Corporate Update

--(BUSINESS WIRE)--Dicerna Pharmaceuticals ... of Litigation Financial Condition and Operating Results For more detailed information and analysis, see Dicerna’s Quarterly Report on Form 10-Q for the q... read more

Looking for another news?


Prometic Reports Second Quarter 2018 Financial Results and Highlights

Commenting on the second quarter 2018 financial results, Bruce Pritchard, Prometic's Chief Operating Officer ... The Corporation also provides access to its proprietary bioseparation technologies to e... read more


NovaBay Pharmaceuticals Inc.: NovaBay Pharmaceuticals Reports Second Quarter 2018 Financial Results

(August 7, 2018) - NovaBay® Pharmaceuticals ... the domestic eye care market, reports financial results for the three and six months ended June 30, 2018 and provides a business update Net product reve... read more

Opiant Pharmaceuticals, Inc. Reports Second Quarter 2018 Financial Results and Provides Corporate Update

Aug. 09, 2018 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals ... today reported financial results for the quarter and six months ended June 30, 2018, and provided a corporate update. "Opiant is in a stron... read more

Eloxx Pharmaceuticals Reports First Quarter 2018 Financial and Operating Results and Provides Business Update

Company on track to initiate Phase 2 clinical trials for investigational drug ELX-02 in cystic fibrosis and cystinosis in 2018 and sufficiently funded to top line data Formation of Scientific Advisory ... read more

Eloxx Pharmaceuticals Reports First Quarter 2018 Financial and Operating Results and Provides Business Update

WALTHAM, Mass., May 10, 2018 (GLOBE NEWSWIRE) -- Eloxx Pharmaceuticals, Inc. (“Eloxx”), (NASDAQ:ELOX) a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel the... read more

Diffusion Pharmaceuticals Reports Second Quarter 2018 Financial Results and Provides Business Update

Aug. 13, 2018 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals ... trans sodium crocetinate (TSC), reports financial results for the three months ended June 30, 2018 and provides a business update. Comme... read more

Eloxx Pharmaceuticals' (ELOX) CEO Bob Ward on Q1 2018 Results - Earnings Call Transcript

Welcome and thank you for joining us this afternoon for review of Eloxx Pharmaceuticals first quarter 2018 financial results and business update. Joining me this afternoon ... section in our most rece... read more

Aerie Pharmaceuticals Reports Second Quarter 2018 Financial Results and Provides Business Update

DURHAM, N.C.--(BUSINESS WIRE)--Aerie Pharmaceuticals ... first-in-class therapies for the treatment of patients with open-angle glaucoma, retina diseases and other diseases of the eye, today reported ... read more

Eloxx Pharmaceuticals Reports First Quarter 2018 Financial and Operating Results and Provides Business Update

On April 30, 2018, the Company closed an underwritten public offering of 5,899,500 shares of common stock at the public offering price of $9.75, raising net proceeds of $53.4 million, after deducting ... read more



FeedsRSS Created by. Full RSS Feed | Privacy Policy | Contact Us